Iconic Therapeutics Lands $10,000,000 Series C Financing

  • Feed Type
  • Date
  • Company Name
    Iconic Therapeutics
  • Mailing Address
    395 Oyster Point Boulevard South San Francisco, CA 94080 USA
  • Company Description
    Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be used to advance development of Iconic’s lead molecule ICON-1 in retinal diseases as well begin clinical trials in ocular melanoma, Iconic’s first oncology indication.
  • M&A Terms
  • Venture Investor
    Xeraya Capital
  • Venture Investor
    MPM Capital
  • Venture Investor
    HBM BioCapital
  • Venture Investor
    H.I.G. Capital
  • Venture Investor
    Lundbeckfond Ventures
  • Venture Investor
    Cormorant Asset Management
  • Venture Investor
    Osage Partners

Trending on Xconomy